The insider sales are too small to signal a change in company outlook. Monitor for upcoming clinical trial catalysts (e.g., Phase 3 data for PHVS) which are the primary drivers for this development-stage biotech. No immediate trading action warranted.
Price Chart
Executive Summary
Insider cluster at Pharvaris N.V. shows two insiders selling shares totaling $584K (0.024% of market cap), with the CMO's sales tied to option exercises. The dollar amount is trivial relative to the $2.4B market cap, and insider sales are weak directional signals. This is a routine liquidity-driven event, not indicative of bearish sentiment.
Key Financial Metrics
Key Facts
- Chief Medical Officer Lu Peng sold 14,700 shares at $34.00 for $500K on June 26, 2026, following option exercises.
- Director Schikan Johannes Gerardus Christiaan Petrus sold 2,400 shares at $35.10 for $84K on June 29, 2026.
- Total open-market sales: $584K, representing 0.024% of Pharvaris' $2.4B market cap.
- All sales were preceded or accompanied by derivative exercises at zero or nominal cost, consistent with routine liquidity and tax planning.
Financial Impact
Total insider sales of $584K are immaterial relative to the $2.4B market cap.
Risk Factors
- Insider sales could increase if the stock appreciates further, but current levels are not alarming.
- Future negative trial results could outweigh any insider activity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PHVS-1782771542669 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $38.06 $36.37 | ▲ +4.44% | ▲ +5.26% | $31.07 (+18.38%) |
Sep 14, 2026 17d ago | 144 | $38.06 $35.20 | ▼ −7.51% | ▼ −9.63% | $31.07 (−18.38%) |
Sep 14, 2026 18d ago | Insider Cluster | $38.86 $36.02 | ▼ −7.31% | ▼ −7.41% | $31.07 (−20.06%) |
Sep 11, 2026 21d ago | Insider Cluster | $38.02 $36.37 | ▼ −4.34% | ▼ −4.12% | $31.07 (−18.29%) |
Sep 8, 2026 24d ago | 6-K | $37.84 $38.86 | ▲ +2.70% | ▲ +3.36% | $31.07 (−17.90%) |
Aug 12, 2026 7w ago | 6-K | $36.46 $36.27 | ▼ −0.52% | ▼ −0.08% | $31.07 (−14.80%) |
Aug 12, 2026 7w ago | Press Release | $36.46 $36.27 | ▼ −0.52% | ▼ −0.08% | $31.07 (−14.80%) |
Aug 6, 2026 8w ago | Press Release | $34.45 $34.04 | ▼ −1.19% | ▼ −2.40% | $31.07 (−9.83%) |
Jul 6, 2026 12w ago | Press Release | $33.22 $35.07 | ▲ +5.57% | ▲ +5.08% | $31.07 (−6.49%) |
Jul 1, 2026 13w ago | Insider Cluster | $33.86 $35.96 | ▲ +6.20% | ▲ +5.27% | $31.07 (−8.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access